<code id='44612E92E7'></code><style id='44612E92E7'></style>
    • <acronym id='44612E92E7'></acronym>
      <center id='44612E92E7'><center id='44612E92E7'><tfoot id='44612E92E7'></tfoot></center><abbr id='44612E92E7'><dir id='44612E92E7'><tfoot id='44612E92E7'></tfoot><noframes id='44612E92E7'>

    • <optgroup id='44612E92E7'><strike id='44612E92E7'><sup id='44612E92E7'></sup></strike><code id='44612E92E7'></code></optgroup>
        1. <b id='44612E92E7'><label id='44612E92E7'><select id='44612E92E7'><dt id='44612E92E7'><span id='44612E92E7'></span></dt></select></label></b><u id='44612E92E7'></u>
          <i id='44612E92E7'><strike id='44612E92E7'><tt id='44612E92E7'><pre id='44612E92E7'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:7714
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          What will Novo Nordisk's VC do with its influx of cash?
          What will Novo Nordisk's VC do with its influx of cash?

          LISELOTTESABROE/Scanpix/AFPviaGettyImagesTheDanishpharmaceuticalcompanyNovoNordiskhasshepherdedallki

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          2023 Nobel Prize in Medicine goes to Karikó and Weissman

          AssociatedPressLONDON—TwopioneersofmRNAresearch—thetechnologythathelpedtheworldtamethevirusbehindthe